With an eye on ‘underserved’ Nordic biotechs, Eir raises €76M toward first fund
The new firm believes Scandinavia offers high-quality science in a market with few dedicated VCs
Newly launched Eir Ventures believes the Nordic countries offer an investment opportunity rich in science that has been underserved by VCs. To help fill the gap, the firm has raised the first €76 million ($85.5 million) toward its first fund, which Eir hopes will top out at about €100
